Cargando…

Biologically Effective Dose and Rectal Bleeding in Definitive Proton Therapy for Prostate Cancer

PURPOSE AND OBJECTIVES: With increasing use of hypofractionation and extreme hypofractionation for prostate cancer, rectal dose-volume histogram (DVH) parameters that apply across dose fractionations may be helpful for treatment planning in clinical practice. We present an exploratory analysis of bi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhangoo, Ronik S., Petersen, Molly M., Bulman, Gabriella F., Vargas, Carlos E., Thorpe, Cameron S., Shen, Jason, Wong, William W., Rwigema, Jean-Claude M., Daniels, Thomas B., Keole, Sameer R., Schild, Steven E., Rong, Yi, DeWees, Todd A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Particle Therapy Co-operative Group 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009455/ https://www.ncbi.nlm.nih.gov/pubmed/35530190 http://dx.doi.org/10.14338/IJPT-21-00007.1

Ejemplares similares

Dose-volume histogram parameters and patient-reported EPIC-Bowel domain in prostate cancer proton therapy
por: Bulman, Gabriella F., et al.
Publicado: (2021)

Patient-reported outcomes for patients with breast cancer undergoing radiotherapy: A single-center registry experience
por: Laughlin, Brady S., et al.
Publicado: (2022)

Initial Quality of Life and Toxicity Analysis of a Randomized Phase 3 Study of Moderately Hypofractionated Radiation Therapy With or Without Androgen Suppression for Intermediate-Risk Adenocarcinoma of the Prostate: PCG GU003
por: Laughlin, Brady S., et al.
Publicado: (2022)

Preliminary Analysis of a Phase II Trial of Stereotactic Body Radiation Therapy for Prostate Cancer With High-Risk Features After Radical Prostatectomy
por: Laughlin, Brady S., et al.
Publicado: (2022)

Patient-reported outcomes version of the common terminology criteria for adverse events and quality-of-life linear analogue self-assessment in breast cancer patients receiving radiation therapy: single-institution prospective registry
por: Thorpe, C. S., et al.
Publicado: (2022)

Clinical Practice Evolvement for Post-Operative Prostate Cancer Radiotherapy—Part 1: Consistent Organs at Risk Management with Advanced Image Guidance
por: Laughlin, Brady S., et al.
Publicado: (2022)

Proton Therapy of Prostate and Pelvic Lymph Nodes for High Risk Prostate Cancer: Acute Toxicity
por: Choo, Richard, et al.
Publicado: (2021)

Intensity Modulated Proton Therapy for Hepatocellular Carcinoma: Initial Clinical Experience
por: Bhangoo, Ronik S., et al.
Publicado: (2021)

Dosimetric comparison of distal esophageal carcinoma plans for patients treated with small‐spot intensity‐modulated proton versus volumetric‐modulated arc therapies
por: Liu, Chenbin, et al.
Publicado: (2019)

Early Outcomes of Patients With Locally Advanced Non-small Cell Lung Cancer Treated With Intensity-Modulated Proton Therapy Versus Intensity-Modulated Radiation Therapy: The Mayo Clinic Experience
por: Yu, Nathan Y., et al.
Publicado: (2019)

Toxicity and outcomes after external beam irradiation for prostate cancer in patients with prior holmium laser enucleation of the prostate: Early experience
por: Laughlin, Brady S., et al.
Publicado: (2022)

Proton therapy for isolated local regional recurrence of breast cancer after mastectomy alone
por: Laughlin, Brady S., et al.
Publicado: (2022)

Proton Therapy in the Adolescent and Young Adult Population
por: Ahmed, Safia K., et al.
Publicado: (2023)

Acute Toxicities and Short-Term Patient Outcomes After Intensity-Modulated Proton Beam Radiation Therapy or Intensity-Modulated Photon Radiation Therapy for Esophageal Carcinoma: A Mayo Clinic Experience
por: Bhangoo, Ronik S., et al.
Publicado: (2020)

Beam angle comparison for distal esophageal carcinoma patients treated with intensity‐modulated proton therapy
por: Feng, Hongying, et al.
Publicado: (2020)

Radiation Recall Dermatitis After the Use of Pralatrexate for Peripheral T-cell Lymphoma
por: Bhangoo, Ronik S., et al.
Publicado: (2018)

Clinical Practice Evolvement for Post-Operative Prostate Cancer Radiotherapy—Part 2: Feasibility of Margin Reduction for Fractionated Radiation Treatment with Advanced Image Guidance
por: Laughlin, Brady S., et al.
Publicado: (2022)

Pilot/Phase II Trial of Hypofractionated Radiation Therapy to the Whole Breast Alone Before Breast Conserving Surgery
por: Thorpe, Cameron S., et al.
Publicado: (2022)

Outcomes of Proton Beam Therapy Compared With Intensity-Modulated Radiation Therapy for Uterine Cancer
por: Anderson, Justin D., et al.
Publicado: (2022)

Long-term outcomes of prostate intensity-modulated radiation therapy incorporating a simultaneous intra-prostatic MRI-directed boost
por: Laughlin, Brady S., et al.
Publicado: (2022)

A method for quantitative evaluations of scanning‐proton dose distributions
por: Allred, Bryce C., et al.
Publicado: (2021)

Beam mask and sliding window-facilitated deep learning-based accurate and efficient dose prediction for pencil beam scanning proton therapy
por: Zhang, Lian, et al.
Publicado: (2023)

Diverticulitis and Rectal Bleeding
por: Gallagher, H. W.
Publicado: (1954)

Impact of planned dose reporting methods on Gamma pass rates for IROC lung and liver motion phantoms treated with pencil beam scanning protons
por: Kang, Yixiu, et al.
Publicado: (2019)

Early Experience Using Proton Beam Therapy for Extremity Soft Tissue Sarcoma: A Multicenter Study
por: Laughlin, Brady S., et al.
Publicado: (2022)

Outcomes and toxicities after proton partial breast radiotherapy for early stage, hormone receptor positive breast cancer: 3-Year results of a phase II multi-center trial
por: Choi, J. Isabelle, et al.
Publicado: (2022)

Assessing concordance between patient-reported and investigator-reported CTCAE after proton beam therapy for prostate cancer
por: Kowalchuk, Roman O., et al.
Publicado: (2021)

Rectal bleeding due to rectal erosion of vaginal mesh
por: Ratneswaren, Anenta, et al.
Publicado: (2015)

Advantages of intensity modulated proton therapy during hippocampal avoidance whole brain radiation therapy
por: Stoker, Joshua, et al.
Publicado: (2018)

Unusual Cause of Rectal Bleeding
por: Garg, Pankaj K., et al.
Publicado: (2011)

Multiple energy extraction reduces beam delivery time for a synchrotron-based proton spot-scanning system
por: Younkin, James E., et al.
Publicado: (2018)

Efficacy and toxicity of rectal cancer reirradiation using IMRT for patients who have received prior pelvic radiation therapy
por: Youssef, Fady F., et al.
Publicado: (2016)

Using Novel Statistical Techniques to Accurately Determine the Predictive Dose Range in a Study of Overall Survival after Definitive Radiotherapy for Stage III Non-Small Cell Lung Cancer in Association with Heart Dose
por: Niska, Joshua R., et al.
Publicado: (2021)

Rectal Bleeding and Abdominal Pain Following Vaccination in a 4-Month-Old Infant
por: Otero, Jaclyn, et al.
Publicado: (2017)

Rectal Bleeding Associated With Chronic Pancreatitis
por: Seiler, Ch., et al.
Publicado: (1991)

Bladder urothelial carcinoma extending to rectal mucosa and presenting with rectal bleeding
por: Aneese, Andrew M, et al.
Publicado: (2017)

Outcome for Children with Metastatic Solid Tumors over the Last Four Decades
por: Perkins, Stephanie M., et al.
Publicado: (2014)

Time to definitive fixation of pelvic and acetabular fractures
por: Devaney, Giles L., et al.
Publicado: (2020)

Prostatic biopsy-related rectal bleeding refractory to medical and endoscopic therapy definitively managed by catheter-directed embolotherapy: a case report
por: De Beule, Tom, et al.
Publicado: (2015)

Effectiveness of Clipping for Definitive Colonic Diverticular Bleeding in Preventing Early Recurrent Bleeding
por: Hayasaka, Junnosuke, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_slg184434fn0blh1v3ms9frm4t